Screener
Mesa Laboratories MLAB Clinical Genomics — Cost Of Goods And Services Sold Depreciation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Mesa Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldDepreciation.
The source filing: Mesa Laboratories’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026808
| Three months ended June 30, 2026 | Sterilization and Disinfection Control | Biopharmaceutical Development | Calibration Solutions | Clinical Genomics | Total |
|---|---|---|---|---|---|
| Revenue (a): | $24,505 | $12,059 | $13,285 | $10,289 | $60,138 |
| Less | |||||
| Depreciation in cost of revenue | 437 | 78 | 111 | 119 | 745 |
| Amortization in cost of revenue | 121 | 379 | - | 191 | 691 |
| Other cost of revenue (b) | 6,788 | 4,020 | 5,143 | 3,739 | 19,690 |
| Total segment cost of revenue | 7,346 | 4,477 | 5,254 | 4,049 | 21,126 |
| Gross Profit (c) | $17,159 | $7,582 | $8,031 | $6,240 | $39,012 |
| Reconciling items: |
Document
FAQ
- What is Mesa Laboratories's clinical genomics — cost of goods and services sold depreciation?
- Mesa Laboratories (MLAB) reported clinical genomics — cost of goods and services sold depreciation of $119K in Q2 2026.
- How has Mesa Laboratories's clinical genomics — cost of goods and services sold depreciation changed year-over-year?
- Mesa Laboratories's clinical genomics — cost of goods and services sold depreciation decreased by 28.3% year-over-year, from $166K to $119K.
- What is the long-term trend for Mesa Laboratories's clinical genomics — cost of goods and services sold depreciation?
- Over 2 years (2024 to 2026), Mesa Laboratories's clinical genomics — cost of goods and services sold depreciation has grown at a -21.5% compound annual growth rate (CAGR), from $937K to $578K.
- What does clinical genomics — cost of goods and services sold depreciation mean?
- This reflects the portion of depreciation expense allocated to the production of goods and services within the Clinical Genomics segment. It represents the systematic allocation of the cost of tangible assets used in the manufacturing process over their useful lives.
Ask your AI about Mesa Laboratories's clinical genomics — cost of goods and services sold depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude